Implementierungsleitfaden Therapieziele Onkologie - Local Development build (v1.0.0-ballot) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

• Narrative Content
• XML
• JSON

: Keimbahn-Testung gBRCA1 – unauffällig (Beispiel)

Raw xml | Download

<Observation xmlns="http://hl7.org/fhir">
  <id value="ObsGBRCAMamma"/>
  <language value="en"/>
  <text>
    <status value="generated"/>
    <div xml:lang="en" lang="en"><hr/><p><b>English</b></p><hr/><p class="res-header-id"><b>Generated Narrative: Observation ObsGBRCAMamma</b></p><a name="en-ObsGBRCAMamma"> </a><a name="en-hcObsGBRCAMamma"> </a><p><b>status</b>: Final</p><p><b>code</b>: <span title="Codes:{http://loinc.org 21639-0}">BRCA1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal</span></p><p><b>subject</b>: <a href="Patient-PatientinMamma.html">Sabine Baumann  Female, DoB: 1977-06-24</a></p><p><b>effective</b>: 2025-09-25</p><p><b>value</b>: <span title="Codes:{http://snomed.info/sct 260385009}">Negative</span></p><p><b>note</b>: </p><blockquote><div><p>gBRCA1/2: keine (wahrscheinlich) pathogene Variante (Klasse 4/5) nachgewiesen.</p>
</div></blockquote></div>
  </text>
  <status value="final"/>
  <code>
    <coding>
      <system value="http://loinc.org"/>
      <code value="21639-0"/>
      <display
               value="BRCA1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal"/>
    </coding>
  </code>
  <subject>🔗 
    <reference value="Patient/PatientinMamma"/>
  </subject>
  <effectiveDateTime value="2025-09-25"/>
  <valueCodeableConcept>
    <coding>
      <system value="http://snomed.info/sct"/>
      <code value="260385009"/>
      <display value="Negative"/>
    </coding>
  </valueCodeableConcept>
  <note>
    <text
          value="gBRCA1/2: keine (wahrscheinlich) pathogene Variante (Klasse 4/5) nachgewiesen."/>
  </note>
</Observation>